Conversely, DND1 protects BIM expression from miR-221 inhibition by competitive binding to BIM, thereby promoting apoptosis in breast cancer cells, but the expression level of DND1 is reduced in breast neoplasmss (48). Here, DND1 is linked to breast carcinoma.